Most of these cancers can be treated effectively with surgery and radioactive iodine therapy, so there is less need for other drugs to treat them. But for cancers in which these treatments aren’t effective, targeted drugs can be helpful.
Sorafenib (Nexavar®) and lenvatinib (Lenvima®) are both the type of expensive targeted drug known as kinase inhibitors. They work in 2 ways. They helps block tumors from forming new blood vessels, which the tumors need to grow. These drugs also target some of the proteins made by cancer cells that normally help them grow.
Some limited resource centers introduced biosimilar target drugs. Do any record result of these biosimilar drugs?
Not that I am aware now, unfortunately... In the next months we will have trials of bioequivalence but for biologicals at A C Camargo Cancer Center, in Sao Paulo, Brazil.
Did you try to talk with the producer of the reference drug - they should know their "competitors"... Of which drug are you asking about?
Not that I am aware now, unfortunately... In the next months we will have trials of bioequivalence but for biologicals at A C Camargo Cancer Center, in Sao Paulo, Brazil.
Did you try to talk with the producer of the reference drug - they should know their "competitors"... Of which drug are you asking about?
- Badges
- Science topic
- Similar topics
- Medicine
- Oncology
- Cancer Research
- Cancer Biology